Drug Discovery World

JULY 18, 2022

Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? I love innovation and working with incredible minds in the pharmaceutical and life science fields who create amazing new technologies and methods of treatment,” says Groetken. His advice?

Big Data 52

Big Data Life Science Development Clinical Trials 52

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 57

Bioinformatics Drugs Genome Genomics 57

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 102

Clinical Trials Clinical Trials Trials Engineer 102

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Auransa, which harnesses available data to discover highly intractable diseases with poorly understood biology.

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113